GlassScriptPhysician profile
Jackie Stuckey
NPI 1689696627
$1,988.92
in general payments reported to CMS, 2019-2025
19 companies · $436 in 2025
The $436 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $380 · 2022: $419 · 2023: $257 · 2024: $497 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,190.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $816.76 | 2021-2025 | Xifaxan |
| Abbvie INC. | $236.86 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $206.80 | 2021-2025 | Farxiga, Breztri |
| Lilly USA, LLC | $188.89 | 2022-2025 | Mounjaro |
| Takeda Pharmaceuticals U.S.A., INC. | $140.87 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.84 | 2021-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $54.72 | 2025 | Caplyta |
| Novo Nordisk INC | $52.32 | 2021-2023 | Rybelsus, Ozempic |
| Pfizer INC. | $45.60 | 2021-2022 | |
| Bausch Health US, LLC | $30.86 | 2021 | |
| Abbott Laboratories | $25.05 | 2025 | Eterna |
| Merck Sharp & Dohme LLC | $23.12 | 2022 | |
| Exact Sciences Corporation | $19.19 | 2024 | Cologuard Collection Kit |
| Medtronic, INC. | $17.86 | 2025 | Intellis Adaptivestim |
| Kowa Pharmaceuticals America, INC. | $17.65 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $15.91 | 2024 | Gvoke Hypopen |
| E.R. Squibb & Sons, L.L.C. | $14.32 | 2021 | |
| Phathom Pharmaceuticals, INC. | $13.43 | 2024 | Voquezna |
| Scynexis, INC. | $12.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jackie Stuckey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.